High-dimensional -omics profiling predicts responses to therapeutic agents in breast cancer cell lines that can be effectively applied to patient selection in clinical trials.
CITATION STYLE
Malik, S., Tan, P., & Ng, P. C. (2013). Molecular fingerprinting catches responders to therapeutic agents. Genome Biology, 14(10). https://doi.org/10.1186/gb-2013-14-10-135
Mendeley helps you to discover research relevant for your work.